Skip to main content

Table 1 Socio-demographic, clinical and operational characteristics of concomitant TB cases found in clusters in Manaus, Amazonas, Brazil (2009–2018)

From: Temporal trends in areas at risk for concomitant tuberculosis in a hyperendemic municipality in the Amazon region of Brazil

Variables Spatial Cluster 1
n = 58,
n (%)
Spatial Cluster
2
n = 77,
n (%)
Temporal
Trend
Cluster 1
n = 15,
n (%)
Temporal Trend Cluster 2
n = 11,
n (%)
Temporal Trend Cluster 3
n = 26,
n (%)
Spatio-temporal Cluster 1
n = 58,
n (%)
All cases
n = 873,
n (%)
Socio-demographics
Age
 0–14 years 2
(3.4)
2
(2.6)
1
(9.1)
19
(1.9)
 15–30 years 19
(32.8)
25
(32.5)
4
(26.7)
3
(27.3)
13
(50.0)
19
(32.8)
307
(35.3)
 31–59 years 32
(55.2)
49
(63.6)
9
(60.0)
6
(54.5)
12
(46.2)
38
(65.5)
483
(55.3)
  ≥ 60 years 5
(8.6)
1
(1.3)
2
(13.3)
1
(9.1)
1
(3.8)
1
(1.7)
64
(7.4)
Gender
 Male 16
(72.4)
54
(70.1)
10
(66.7)
11
(100.0)
20
(76.9)
40
(69.0)
618
(70.8)
 Female 42
(27.6)
23
(29.9)
5
(33.3)
6
(23.1)
18
(31.0)
255
(29.2)
Race/color
 Yellow 04
(0.5)
 White 9
(15.5)
7
(9.1)
2
(13.3)
3
(11.5)
6
(10.3)
96
(11.0)
 Brown 47
(81.0)
67
(87.0)
13
(86.7)
11
(100.0)
23
(88.5)
50
(86.2)
739
(84.7)
 Black 2
(2.6)
2
(3.4)
19
(2.2)
 Indigenous 1
(1.7)
1
(1.3)
05
(0.6)
 Ignored 1
(1.7)
10
(1.1)
Education
 Illiterate 23
(2.6)
 Primary 18
(31.1)
24
(31.2)
4
(26.6)
1
(9.1)
5
(19.2)
19
(32.8)
299
(34.2)
 Incomplete high school 3
(5.2)
10
(13.0)
1
(6.7)
1
(9.1)
5
(19.2)
6
(10.3)
89
(10.2)
 Complete high school 25
(43.1)
27
(35.1)
9
(60.0)
5
(45.5)
12
(46.2)
24
(41.4)
254
(29.1)
 Incomplete undergraduate 3
(5.2)
4
(5.2)
1
(3.8)
1
(1.7)
37
(4.2)
 Complete undergraduate 3
(5.2)
2
(2.6)
2
(18.2)
3
(11.5)
1
(1.7)
30
(3.4)
 Ignored 6
(10.3)
10
(13.0)
1
(6.7)
2
(18.2)
141
(16.2)
Profession/Employment
 Unemployed 3
(3.9)
9
(11.7)
1
(6.5)
1
(3.9)
6
(10.4)
18
(2.0)
 Formal Work 4
(5.4)
5
(6.5)
3
(20.1)
1
(3.9)
2
(3.4)
47
(5.4)
 Informal Work 10
(17.0)
10
(13.0)
3
(20.1)
3
(11.4)
6
(10.3)
156
(17.9)
 Ignored 41
(70.7)
53
(68.8)
8
(53.3)
11
(100.0)
21
(80.8)
44
(75.9)
652
(74.7)
Beneficiary cash transfer programs
 No 20
(34.5)
29
(37.7)
2
(13.3)
10
(9.1)
19
(73.1)
28
(48.3)
421
(48.2)
 Yes 1
(1.7)
5
(6.5)
4
(6.9)
25
(2.9)
 Ignored 37
(63.8)
43
(55.8)
13
(86.7)
1
(90.9)
7
(26.9)
26
(44.8)
427
(48.9)
Clinical-operational
Type of case
  New 56
(96.6)
69
(89.6)
15
(100.0)
10
(90.9)
25
(96.2)
52
(89.7)
808
(92.6)
  Relapse 1
(1.7)
4
(5.2)
1
(9.1)
5
(8.6)
30
(3.4)
  Retreatment 3
(3.9)
1
(1.7)
15
(1.7)
  Ignored\others 1
(1.7)
1
(1.3)
1
(3.8)
02
(0.2)
Outcome
  Abandonment 5
(8.6)
11
(14.3)
2
(13.3)
(7.7) 7
(12.1)
02
(0.2)
  Cure 37
(63.8)
39
(50.6)
7
(46.7)
6
(54.5)
(57.7) 28
(48.3)
469
(53.7)
  Bankruptcy/Resistance 2
(3.4)
4
(5.2)
(3.8) 6
(10.3)
50
(5.7)
  Diagnostic Change 1
(1.7)
4
(5.2)
1
(6.7)
(3.8) 2
(3.4)
34
(3.9)
  Death from other causes 6
(10.3)
9
(11.7)
2
(13.3)
2
(18.2)
(11.5) 8
(13.8)
44
(5.0)
  Death with TB as a basic cause 4
(6.9)
6
(7.8)
3
(20.0)
(3.8) 2
(3.4)
100
(11.5)
  State/country Transfer 2
(3.4)
1
(9.1)
127
(14.5)
  Ignored 1
(1.7)
4
(5.2)
2
(18.2)
(11.5) 5
(8.6)
47
(5.4)
TB-HIV co-infection
  No 21
(36.2)
28
(36.4)
6
(40.0)
1
(9.1)
9
(34.6)
18
(31.0)
214
(24.5)
  Yes 36
(62.1)
49
(63.6)
8
(53.3)
9
(81.8)
17
(65.5)
40
(69.0)
540
(61.9)
  Test not performed 103
(11.7)
  Ignored 1
(1.7)
1
(6.7)
1
(9.1)
16
(1.9)
TB-diabetes comorbidity
  No 53
(91.4)
74
(96.1)
14
(93.3)
9
(81.8)
23
(88.5)
56
(96.6)
819
(93.8)
  Yes 4
(6.9)
3
(3.9)
1
(6.7)
1
(9.1)
3
(11.5)
2
(3.4)
37
(4.2)
  Ignored 1
(1.7)
1
(9.1)
17
(1.9)
Alcoholism
  No 48
(82.8)
60
(77.9)
12
(80.0)
9
(81.8)
19
(73.1)
42
(72.4)
704
(80.6)
  Yes 7
(12.1)
15
(19.5)
2
(13.3)
1
(9.1)
7
(26.9)
14
(24.1)
140
(16.0)
  Ignored 3
(5.2)
2
(2.6)
1
(6.7)
1
(9.1)
2
(3.4)
29
(3.3)
Drug addiction
  No 18
(31.0)
22
(28.6)
3
(20.0)
3
(27.3)
9
(34.6)
18
(31.0)
401
(45.9)
  Yes 2
(65.5)
7
(9.1)
1
(6.7)
1
(9.1)
1
(3.8)
3
(5.2)
65
(7.4)
  Ignored 38
(3.4)
48
(62.3)
11
(73.3)
7
(63.6)
16
(61.5)
37
(63.8)
407
(46.6)
Smoking
  No 16
(25.6)
25
(62.3)
2
(13.3)
3
(27.3)
10
(38.5)
20
(34.5)
388
(44.4)
  Yes 4
(6.9)
4
(5.2)
2
(13.3)
1
(9.1)
1
(1.7)
80
(9.2)
  Ignored 38
(65.5)
48
(62.3)
11
(73.3)
(7
63.6)
16
(61.5)
37
(63.8)
405
(46.4)
Directly observed treatment
  No 21
(36.2)
20
(26.0)
8
(53.3)
1
(9.1)
7
(26.9)
15
(25.9)
285
(32.6)
  Yes 8
(13.8)
10
(13.0)
3
(20.0)
1
(3.8)
5
(8.6)
104
(11.9)
  Ignored 29
(50.0)
47
(61.0)
4
(26.7)
10
(90.9)
18
(69.2)
38
(65.5)
484
(55.4)
Clinical form
  Intestinal 3
(5.1)
2
(2.6)
1
(6.7)
1
(9.1)
2
(7.6)
4
(8.0)
29
(3.3)
  Peritoneal 2
(2.6)
1
(1.7)
07
(0.8)
  Disseminated 1
(1.3)
1
(1.7)
05
(0.6)
  Ganglionar 04
(0.5)
  Abdominal 1
(1.3)
1
(1.7)
03
(0.4)
  Pericardial 1
(1.7)
03
(0.4)
  Cerebral 02
(0.3)
  Others 2
(3.5)
1
(6.7)
1
(3.8)
10
(1.1)
  Missing 58
(89.7)
71
(92.2)
13
(86.7)
10
(90.9)
23
(88.5)
51
(87.9)
810
(92.8)